| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/14/2008 | CN101177700A Methods and means for producing proteins with predetermined post-translational modifications |
| 05/14/2008 | CN100387718C Proteinase K resistant surface protein of neisseria meningitidis |
| 05/14/2008 | CN100387713C Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 05/14/2008 | CN100387709C Anti HBeAg monoclone antibody cell strain, preparation method and anti HBeAg monoclone antibody |
| 05/14/2008 | CN100387708C Method for high level expression of active lymphotoxin-betareceptor immunoglobulin and purification method therefor |
| 05/14/2008 | CN100387622C Strategically modified hepatitis b core proteins and their derivatives |
| 05/14/2008 | CN100387621C Production of antihuman antigen receptors and use thereof |
| 05/14/2008 | CN100387617C HIV peptides, antigens, vaccine compositions, immunoassay kit and method of detecting |
| 05/13/2008 | US7371849 Methods of constructing camel antibody libraries |
| 05/13/2008 | US7371845 MAGE-A3 peptides presented by HLA class II molecules |
| 05/13/2008 | US7371835 p53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 05/13/2008 | US7371832 Polynucleotides encoding molecules associated with cell proliferation |
| 05/13/2008 | US7371829 Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites |
| 05/13/2008 | US7371828 Extracellular signal-regulated kinase sequences and methods of production and use |
| 05/13/2008 | US7371827 Antibodies against the PRO1126 polypeptide |
| 05/13/2008 | US7371826 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 05/13/2008 | US7371825 Monoclonal antibody inhibits ability of monocyte chemoattractant protein (MCP) to cause chemotactic migration to monocytic cells and prevents calcium mobilization; diagnosis and treatment of prostate and colon cancer |
| 05/13/2008 | US7371824 PRO6093 polypeptides |
| 05/13/2008 | US7371822 Polypeptide of given sequence; use in prevention and treatment of cardiovascular, metabolic, inflammatory disorders; |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371815 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 05/13/2008 | US7371811 Polypeptide of given sequence; diagnosis and treatment of bipolar disorders |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
| 05/13/2008 | US7371572 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371386 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/13/2008 | US7371384 Compositions and methods of using angiopoietin-like 4 protein antibody |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371382 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 05/13/2008 | US7371381 Anti-galanin antibodies and uses thereof |
| 05/13/2008 | US7371380 Anti-Cark antibodies and uses therefor |
| 05/13/2008 | US7371379 Epidermal growth factors (ErbB2); gene expression inhibition; anticancer agents |
| 05/13/2008 | US7371378 Anticancer agents; genetic engineering; monoclonal antibodies |
| 05/13/2008 | US7371377 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; tissue engineering; bradycardial agents |
| 05/13/2008 | US7371371 Interleukin-2 mutants with reduced toxicity |
| 05/13/2008 | US7371366 GlcNAc phosphotransferase of the lysosomal targeting pathway |
| 05/13/2008 | US7371364 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2315239C Nucleotide and protein sequence of mammastatin and methods of use |
| 05/13/2008 | CA2302147C Methods for protein screening |
| 05/13/2008 | CA2216658C Hapten-carrier conjugates for use in drug-abuse therapy |
| 05/13/2008 | CA2166291C Htlv-iinra compositions and assays for detecting htlv infection |
| 05/08/2008 | WO2008054606A2 High affinity human antibodies to human il-4 receptor |
| 05/08/2008 | WO2008054184A1 Composition for treatment of cervix cancer |
| 05/08/2008 | WO2008053901A1 METHOD FOR ANALYSIS OF HEPATITIS B VIRUS s ANTIGEN |
| 05/08/2008 | WO2008053573A1 Remedy for malignant neoplasm |
| 05/08/2008 | WO2008053275A2 Novel collection of hcdr3 regions and uses therefor |
| 05/08/2008 | WO2008052798A2 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs |
| 05/08/2008 | WO2008052796A1 Fgfr4 antibodies |
| 05/08/2008 | WO2008052489A1 Recombinant antibodies against vascular endothelial growth factor (vegf) |
| 05/08/2008 | WO2008052322A1 Immunotoxγn fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
| 05/08/2008 | WO2008033105A8 Hemagglutinin antibody and uses thereof |
| 05/08/2008 | WO2008008482A9 Altered br3-binding polypeptides |
| 05/08/2008 | WO2007146172A3 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 05/08/2008 | WO2006116609A8 Methods for treating lower motor neuron diseases and compositions for the same |
| 05/08/2008 | WO2006076691A8 Irta-2 antibodies and their uses |
| 05/08/2008 | WO1999048916A8 Hypoxia-inducible human genes, proteins, and uses thereof |
| 05/08/2008 | US20080109925 Transcriptional Regulatory Nucleic Acids, Polypeptides and Methods of Use Thereof |
| 05/08/2008 | US20080109923 Expression of spider silk proteins in higher plants |
| 05/08/2008 | US20080109917 Card-domain containing polypeptides, encoding nucleic acids, and methods of use |
| 05/08/2008 | US20080108798 Matrix comprising modified cell adhesion protein for use in designing immunoglobulin mimics |
| 05/08/2008 | US20080108797 Modified Human Growth Hormone Polypeptides and Their Uses |
| 05/08/2008 | US20080108796 Human IL-1 epsilon DNA and polypeptides |
| 05/08/2008 | US20080108795 Reagents for the detection of protein phosphorylation in EGFR-signaling pathways |
| 05/08/2008 | US20080108794 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 05/08/2008 | US20080108793 Novel purified FabI polypeptides from fransicella tularensis |
| 05/08/2008 | US20080108565 An immunoglobulin heavy chain variable region, an immunoglobulin light chain variable region, together define a single binding site for binding human HGF; neutralizing the activity of HGF |
| 05/08/2008 | US20080108563 Glial Cell line-derived Neurotrophic Factor Receptor; neuronal disorders, Parkinson's, Alzheimers or neuronal injury |
| 05/08/2008 | US20080108560 Heterologous G-Csf Fusion Proteins |
| 05/08/2008 | US20080108547 Protease Inhibitor |
| 05/08/2008 | US20080108514 Novel fab fragment libraries and methods for their use |
| 05/08/2008 | US20080108511 Genes and gene products differentially expressed during heart failure |
| 05/08/2008 | US20080108507 Method for in vitro molecular evolution of protein function |
| 05/08/2008 | US20080108152 Preparing immunoglobulin specific for deglycosylated membrane proteins; for use in monitoring dynamic organization of the plasma membranes |
| 05/08/2008 | US20080108138 Solid support comprising thin film and immobilized cell fate modulator for use in controlling tissue development in a three-dimensional environment |
| 05/08/2008 | US20080108135 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |
| 05/08/2008 | US20080108133 Adenocarcinoma Specific Antibody Sam-6, and Uses Thereof |
| 05/08/2008 | US20080108129 Using replication defective vectors to generate tumor specific immunoglobulins; tissue targeted therapy; immunotherapy |
| 05/08/2008 | US20080108127 Plant Activation of Insect Toxin |
| 05/08/2008 | US20080108107 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 05/08/2008 | US20080108105 Transcription factor for enhancing genic expression in microorganismal host |
| 05/08/2008 | US20080108092 Tumor suppressor specific immunoblobulin for use in diagnosis/prognosis of cell proliferative disorders of prostate |
| 05/08/2008 | US20080108089 Methods for predicting pregnancy outcome in a subject by hCG assay |
| 05/08/2008 | US20080108088 Using g protein coupled receptor to identify modulators of taste signal transduction; generating of taste topographic maps that elucidate relationship between taste cells of tongue and taste sensory neurons in brain |
| 05/08/2008 | US20080108084 Cancer Detection Methods and Reagents |
| 05/08/2008 | US20080108053 Compositions and methods for purifying and crystallizing molecules of interest |
| 05/08/2008 | US20080108050 Cellular polyadenylation and specificity factor 3 (CPSF30)/non-structural protein 1 (NS1) complex for use in designing vaccine for viral respiratory disorders in avian a nd mammals; viricides |
| 05/08/2008 | US20080107705 Administering locally for disc disorders |
| 05/08/2008 | US20080107680 Linked to polyoxyethylene glycol via oximination |
| 05/08/2008 | US20080107676 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107675 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107674 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/08/2008 | US20080107673 Clostridial polypeptide for use in prevention and treatment of microorganismal infcetion |
| 05/08/2008 | US20080107672 Mutant viral antigen for use in diagnosing hepatitis; immunoassay |
| 05/08/2008 | US20080107670 Antigenic peptides based on gag protein conserved regions for use in treatment and prevention of viral infection; viricides |
| 05/08/2008 | US20080107668 Oligopeptides comprising epitopic sequences for use in induction of killer lymphocyte response in treatment of cell proliferative disorders |
| 05/08/2008 | US20080107662 Immunogenic Peptides, Nucleic Acids Encoding The Same And Use Thereof In Cancer Treatment And Diagnosis |
| 05/08/2008 | US20080107660 Binding Agents |
| 05/08/2008 | US20080107658 Nerve growth specific chimerikc ligand comping immunoglobulin component for use in treatment and prevention of arthritic, skin, viral, inflammatory, respiratory and pain disorders |